MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ:MIRA
MIRA Stock Chart & Stats
$1.46
-$0.17(-11.07%)
At close: 4:00 PM EST
$1.46
-$0.17(-11.07%)
Day’s Range― - ―
52-Week Range$0.90 - $2.45
Previous CloseN/A
Volume531.69K
Average Volume (3M)6.20M
Market Cap
$39.50M
Enterprise Value$39.73M
Total Cash (Recent Filing)$9.41M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.12
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.44
Shares Outstanding42,022,087
10 Day Avg. Volume16,811,281
30 Day Avg. Volume6,198,037
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)3.44
Price to Sales (P/S)0.00
P/FCF Ratio-7.68
Enterprise Value/Market Cap1.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-4.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.18
Revenue Forecast (FY)N/A
MIRA Pharmaceuticals, Inc. News
MIRA FAQ
What was MIRA Pharmaceuticals, Inc.’s price range in the past 12 months?
MIRA Pharmaceuticals, Inc. lowest stock price was $0.90 and its highest was $2.45 in the past 12 months.
What is MIRA Pharmaceuticals, Inc.’s market cap?
MIRA Pharmaceuticals, Inc.’s market cap is $39.50M.
When is MIRA Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MIRA Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is MIRA Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts MIRA Pharmaceuticals, Inc.’s price is currently Overvalued.
Does MIRA Pharmaceuticals, Inc. pay dividends?
MIRA Pharmaceuticals, Inc. does not currently pay dividends.
What is MIRA Pharmaceuticals, Inc.’s EPS estimate?
MIRA Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MIRA Pharmaceuticals, Inc. have?
MIRA Pharmaceuticals, Inc. has 42,022,087 shares outstanding.
What happened to MIRA Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MIRA Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in MIRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MIRA Pharmaceuticals, Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 12.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.7%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.62%
12-Months-Change
Fundamentals
Return on Equity
-140.83%
Trailing 12-Months
Asset Growth
575.82%
Trailing 12-Months
Company Description
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and the cognitive impairments frequently observed in adult patients suffering from early-stage dementia. The firm's lead candidate, MIRA1a, is a synthetic cannabinoid analog engineered to alleviate both anxiety and chronic pain through its interaction with cannabinoid type 1 and type 2 receptors. Originally established in 2020 as MIRA1a Therapeutics, Inc., MIRA Pharmaceuticals, Inc. maintains its headquarters in Baltimore, Maryland.
Technical Analysis
Ownership Overview
8.45% Insiders
2.23% Mutual Funds
1.29% Other Institutional Investors
85.63% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---